XML 31 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Combinations (Tables)
 6 Months Ended
Jun. 30, 2018
Mapi Group [Member]  
Schedule of summary of recognized identified assets acquired and liabilities assumed
The table following summarizes the Company’s provisional estimates of the fair values of the assets acquired and liabilities assumed:
 
July 27, 2017

 
(in thousands)

Cash
$
19,649

Property, plant and equipment 
4,872

Goodwill*
129,344

Intangible assets** 
32,330

Accounts receivable
15,874

Unbilled revenue
6,984

Prepayments and other current assets
2,587

Other receivables
1,430

Income taxes receivable 
4,262

Accounts payable
(2,994
)
Payments on account
(31,445
)
Other liabilities
(24,952
)
Non-current other liabilities 
(1,061
)
Non-current deferred tax liability 
(11,104
)
 
 
Net assets acquired
$
145,776

 
 
Cash outflows 
$
144,131

Working capital adjustment
1,645

Total consideration
$
145,776

 
*Goodwill represents the acquisition of an established workforce with experience in late phase commercialization, analytics, real world evidence generation and strategic regulatory services in clinical trial services for biologics, drugs and devices. Goodwill related to the business acquired is not tax deductible.
**The Company has made an initial estimate of separate intangible assets acquired of $32.3 million, being customer relationships and order book assets.  This assessment is under review and will be finalized within 12 months of the date of acquisition.
Clinical Research Management Inc.  
Schedule of summary of recognized identified assets acquired and liabilities assumed
The acquisition of ClinicalRM has been accounted for as a business combination in accordance with FASB ASC 805 Business Combinations. The table following summarizes the fair values of the assets acquired and liabilities assumed:
 
September 15, 2016

 
(in thousands)

Cash
$
3,168

Property, plant and equipment
939

Goodwill*
35,969

Customer lists
4,012

Order backlog
1,668

Brand
1,409

Accounts receivable
11,431

Unbilled revenue
3,868

Prepayments and other current assets
1,673

Accounts payable
(165
)
Other liabilities
(5,569
)
Non-current other liabilities
(7
)
 
 
Net assets acquired
$
58,396

 
 
Total consideration
$
58,396

 
*Goodwill represents the acquisition of an established workforce with experience in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs and devices. Goodwill related to the US portion of the business acquired is tax deductible.